OTC

Strength

.667; 10; 20 mg/5mL; mg/5mL; mg/5mL

NDC

12830081616

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Last Updated

6/19/2024

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

10/13/2011

Pharmacological Classes

Adrenergic alpha-Agonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+11.4%

5Y

+11.4%

All

+14.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.